BRAF inhibitor vemurafenib improves the antitumor activity of adoptive cell immunotherapy
(Q36175312)
scientific article
scientific article
Language:
Current Data About
BRAF inhibitor vemurafenib improves the antitumor activity of adoptive cell immunotherapy